United Therapeutics (UTHR) Other Non Operating Income (2009 - 2026)

United Therapeutics has disclosed Other Non Operating Income across 18 years of filings, most recently posting $13.3 million for Q2 2026.

• In Q2 2026, Other Non Operating Income rose 13400.0% year-over-year to $13.3 million; the TTM figure through Jun 2026 stood at $20.3 million (up 1791.67% YoY), while the FY2025 annual figure was $48.9 million, up 743.1% from the prior year.
• Other Non Operating Income came in at $13.3 million for Q2 2026 at United Therapeutics, up from -$46.3 million in the prior quarter.
• In the past five years, Other Non Operating Income ranged from a high of $47.2 million in Q4 2025 to a low of -$51.8 million in Q2 2022.
• Average Other Non Operating Income over 5 years is -$1.8 million, with a median of -$600000.0 recorded in 2023.
• Year-over-year, Other Non Operating Income slumped 1818.52% in 2022 and surged 13400.0% in 2026.
• Over 5 years, Other Non Operating Income stood at -$5.3 million in 2022, then surged by 88.68% to -$600000.0 in 2023, then slumped by 333.33% to -$2.6 million in 2024, then jumped by 1915.38% to $47.2 million in 2025, then sank by 71.82% to $13.3 million in 2026.
• Per Business Quant data, the three most recent Other Non Operating Income figures were $13.3 million in Q2 2026, -$46.3 million in Q1 2026, and $47.2 million in Q4 2025.